Prenetics is one of the fastest growing and largest health tech, diagnostic and genetic testing companies globally. Prenetics was established as a unicorn in 2021, recently followed by a successful listing on the NASDAQ stock exchange, New York. Now is the time to join our scale-up journey, with an innovative product pipeline planned within the next 12 months.Prenetics’ mission is to decentralise healthcare. This means testing at-home, taking control of your own health and being the best version of yourself over time. Our DNAfit product is recognised through multiple awards such as The Queen’s Award for Innovation and BT’s Sport Industry Awards. And our enterprise Covid-19 testing solutions helped keep Heathrow Airport flying and got the English Premier League back on track. Now, attention is on revolutionising personal healthcare for the better, as evidenced by the launch of our Coloclear and Snapshot products in Asia, with more to come very soon.
| Website | https://www.prenetics.uk/ |
| Revenue | $18.4 million |
| Employees | 33 (3 on RocketReach) |
| Founded | 2013 |
| Industry | Biotechnology |
| Keywords | Health Tech, Diagnostic Testing, Genetic Testing, Molecular Diagnostics, Precision Medicine, Dna Testing, At Home Diagnostics, Medical Diagnostics, Clinical Diagnostics, Genetic Screening, Biotechnology, Medical Technology, Healthcare It, Digital Health, Telehealth, Home Testing Kits, Virtual Care, Disease Screening, Nasdaq Listed |
| Competitors | 23andMe Inc, Ancestry, MyHeritage, Fulgent Genetics, Invitae, Color, Genomics England, Everly Health, Thermo Fisher Scientific, Labcorp +35 more (view full list) |
Looking for a particular Prenetics EMEA employee's phone or email?
Prenetics EMEA Questions
The Prenetics EMEA annual revenue was $18.4 million in 2026.
Syrus Nourbakhsh is the Vice President Product of Prenetics EMEA.
3 people are employed at Prenetics EMEA.
Top Prenetics EMEA Employees
Related Companies
